Linoleic acid ameliorates adenine-induced CKD in rats by regulating p38 MAPK and PPARα pathways related oxidative and metabolic stress responses

Abstract Objective This study investigated the protective effects of linoleic acid (LA) on adenine‑induced chronic kidney disease (CKD) in rats and its underlying mechanisms. Methods A CKD rat model was established by oral gavage of 2.5% adenine, with LA and inulin as intervention and positive control, respectively. Renal function was evaluated by measuring serum blood urea nitrogen (BUN) and creatinine (Scr), and histopathology by hematoxylin and eosin (H&E) and Masson's trichrome staining. Triglycerides (TG), total cholesterol (T-CHO), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), TNF-α and IL-6 were determined using commercial assay kits. Levels of glutathione (GSH), malondialdehyde (MDA), superoxide dismutase (SOD), and iron were also measured. Protein expression of ACSL4, GPX4, and PTGS2 was examined by Western blotting. Network pharmacology and molecular docking predicted potential targets and signaling pathways, followed by Western blot validation of PPARα expression and p38 MAPK phosphorylation. Results LA significantly decreased levels of Scr and BUN, and attenuated renal histopathological injury, reversed dyslipidemia, and reduced TNF-α and IL-6 levels in CKD rats. LA also suppressed ferroptosis, as evidenced by decreased iron and MDA, increased GSH and SOD, decreased levels of ACSL4 and PTGS2, and upregulated expression of GPX4. Molecular docking revealed direct binding of LA to core targets including MAPK14 and PPARα. Western blot analysis confirmed that LA upregulated PPARα and inhibited p38 MAPK phosphorylation, thereby suppressing ferroptosis. Conclusion LA exerts protective effects in CKD rats by modulating ferroptosis through suppression of the p38 MAPK/ACSL4/PTGS2 pro-ferroptotic axis and activation of the PPARα/GPX4 anti-ferroptotic axis.

Authors

Institutions

Publication Details

Journal
Nutrire
Published
2026-11-16
DOI
https://doi.org/10.1186/s41110-026-00553-5
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Linoleic acid ameliorates adenine-induced CKD in rats by regulating p38 MAPK and PPARα pathways related oxidative and metabolic stress responses

Zelin Zhu, Haining Yu, Yangyi Jiang
4 links
Nutrire
Chronic Kidney Disease and Diabetes
article

Linoleic acid ameliorates adenine-induced CKD in rats by regulating p38 MAPK and PPARα pathways related oxidative and metabolic stress responses

Zelin Zhu, Haining Yu, Yangyi Jiang
article en

Abstract

Abstract Objective This study investigated the protective effects of linoleic acid (LA) on adenine‑induced chronic kidney disease (CKD) in rats and its underlying mechanisms. Methods A CKD rat model was established by oral gavage of 2.5% adenine, with LA and inulin as intervention and positive control, respectively. Renal function was evaluated by measuring serum blood urea nitrogen (BUN) and creatinine (Scr), and histopathology by hematoxylin and eosin (H&E) and Masson's trichrome staining. Triglycerides (TG), total cholesterol (T-CHO), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), TNF-α and IL-6 were determined using commercial assay kits. Levels of glutathione (GSH), malondialdehyde (MDA), superoxide dismutase (SOD), and iron were also measured. Protein expression of ACSL4, GPX4, and PTGS2 was examined by Western blotting. Network pharmacology and molecular docking predicted potential targets and signaling pathways, followed by Western blot validation of PPARα expression and p38 MAPK phosphorylation. Results LA significantly decreased levels of Scr and BUN, and attenuated renal histopathological injury, reversed dyslipidemia, and reduced TNF-α and IL-6 levels in CKD rats. LA also suppressed ferroptosis, as evidenced by decreased iron and MDA, increased GSH and SOD, decreased levels of ACSL4 and PTGS2, and upregulated expression of GPX4. Molecular docking revealed direct binding of LA to core targets including MAPK14 and PPARα. Western blot analysis confirmed that LA upregulated PPARα and inhibited p38 MAPK phosphorylation, thereby suppressing ferroptosis. Conclusion LA exerts protective effects in CKD rats by modulating ferroptosis through suppression of the p38 MAPK/ACSL4/PTGS2 pro-ferroptotic axis and activation of the PPARα/GPX4 anti-ferroptotic axis.

NutrireVol. 51(2)
Zhejiang University of Technology (CN)
Good health and well-being
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon